Butwe are not satisfied with our performance in other key areas of fixed incometrading and in asset management, and we are taking steps to deliver betterresults in those businesses. These initiatives include hiring to add key tradingand investment management talent, expanding our client flow business, increasingcapital commitments in a disciplined way and rationalizing costs in targetedareas. It said the increases reflected falling home prices and theimpact of a deteriorating economy on commercial, commercialreal estate and consumer loans. Second-quarter net income applicable to common shareholdersof the Minneapolis-based bank fell to $221 million, or 12 centsper share, from $926 million, or 53 cents, a year earlier Netrevenue rose 9 percent to $4.16 billion.
Analysts on average expected profit of 10 cents per shareon revenue of $4.02 billion, Reuters Estimates said. Results included charges per share of 8 cents tied to therepayment of a government bailout and 5 cents to replenish afederal deposit insurance fund U.S. Bancorp set aside $1.4 billion for credit losses inthe quarter, and net charge-offs totaled $929 million, bothmore than twice the year-earlier levels. * EPS 12 cents; Street view 10 cents Stocks | Bonds * Record mortgage production (Adds financial details, background throughout) NEW YORK, July 22 (Reuters) – U.S Bancorp (USB.N), one ofthe 10 largest U.S. banks, on Wednesday said second-quarterprofit fell 76 percent, a smaller decline than expected, as thedeteriorating economy drove credit losses higher. The results show how the recession and credit crisis havenot spared even lenders considered relatively conservative.U.S. Bancorp’s mix of businesses is less directly exposed tothe health of consumer borrowers than that at many rivals.
It gave the system a low chance of less than 30 percent of becoming a tropical cyclone over the next 48 hours.Elsewhere, the NHC pointed to disorganized cloudiness and thunderstorms over the Bahamas. oil and natural gas platforms and refineries along the coast.Commodities traders likewise watch storms that could hit agriculture crops like citrus and cotton in Florida and other states along the Gulf coast to Texas.(Reporting by Scott DiSavino; Editing by John Picinich) Green Business Mexico. TheBahamas system showed no signs of development and NHC gave it a low chance of less than 30 percent of becoming a tropical cyclone over the next 48 hours.If either system, however, does develop into a tropical storm with winds of 39 to 73 miles per hour, it would be named Ana, the first named storm of the Atlantic hurricane season.By this time last year, there were already four named storms in the Atlantic basin.Energy traders watch for storms that could enter the Gulf of Mexico and threaten U.S. National Hurricane Center and weather models forecast Wednesday. Green Business | MexicoOver the next five days, the system will cross through the Bahamas before turning northeast away from Florida and into the Atlantic Ocean, most weather models predicted.The NHC said upper level winds and interaction with land, the Dominican Republic and Haiti, did not favor develop of the system.
CONTACT:Ted KarkusMediaInvestor RelationsChairman of the Board, CEOKaren PinemanCarl HymansThe Quigley Corporation G.S Schwartz & Co.G.S. Schwartz & Co.(215) 345-0919(212) 725-4500 (212) SOURCEQuigley CorporationTed Karkus, Chairman of the Board, CEO of The Quigley Corporation,+1-215-345-0919; or Media, Karen Pineman, , or InvestorRelations, Carl Hymans, , both of G.S Schwartz & Co.,+1-212-725-4500. NEW YORK (Reuters) – A tropical wave over the Dominican Republic and Haiti won’t develop into a tropical cyclone over the next day or so, and will not reach the oil rich Gulf of Mexico, the U.S. Factors that impact such forward-looking statementsinclude, among others, changes in worldwide general economic conditions,changes in interest rates, government regulations, and worldwide competition. consists of an FDA approved facilityto manufacture COLD- EEZE(R) lozenges as well as fulfill other contractmanufacturing opportunities.
Quigley Pharma Inc.( http://) conducts research in order to develop andcommercialize a pipeline of patented botanical and naturally derived potentialprescription drugs.Forward-Looking StatementsCertain statements in this press release are “forward-looking statements”within the meaning of the Private Securities Litigation Reform Act of 1995 andinvolve known and unknown risk, uncertainties and other factors that may causethe Company’s actual performance or achievements to be materially differentfrom the results, performance or achievements expressed or implied by theforward-looking statement. The Quigley Corporation has several wholly ownedsubsidiaries; Quigley Manufacturing Inc. Its Cold Remedy segment isa leading marketer and manufacturer of the COLD-EEZE(R) family of lozenges,gums and sugar free tablets clinically proven to cut the common cold nearly inhalf. COLD-EEZE customers include leading national wholesalers anddistributors, as well as independent and chain food, drug and mass merchandisestores and pharmacies. The secondary efficacy objective is to demonstrate that treatment with QR-333improves symptomatic diabetic neuropathy, as demonstrated through the SymptomAssessment Score, Quality of Life questionnaires, and sleep questionnaires.Safety:Safety variables included adverse events (AEs), findings from physical andexaminations, vital signs, laboratory safety data, 12-lead electrocardiograms(ECGs), and nerve conduction velocity (NCV) assessments.About The Quigley CorporationThe Quigley Corporation (NASDAQ: QGLY, http://) is adiversified natural health medical science company. Number of patients (planned and analyzed): The planned sample size of evaluable patients was 70 per arm (140 in total). Two hundred nineteen patients were randomized and enrolled; 109 and 110patients were randomized to placebo and QR-333 treatment group, respectively.